1-(2-甲基-2-丁烷基)哌嗪 | 147539-55-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 1-(2-甲基-2-丁烷基)哌嗪
• 中文别名: 放线菌素D,7-[(羟基乙酰基)氨基]-,酯和L-缬氨酰羟基乙酰基-L-缬氨酸(9CI)
• 英文名称: 1-(1,1-dimethylpropyl)piperazine
• 英文别名: 1-(2-Methylbutan-2-yl)piperazine
• CAS: 147539-55-7
• 化学式: C₉H₂₀N₂
• 分子量: 156.271
• InChiKey: YNTQDSJCTVCNPU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(4-氯苯甲酰)丙酸 、 1-(2-甲基-2-丁烷基)哌嗪 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 、 二氯甲烷 为溶剂， 反应 5.5h， 生成 1-(4-Chloro-phenyl)-4-[4-(1,1-dimethyl-propyl)-piperazin-1-yl]-butane-1,4-dione; hydrochloride
  参考文献：
  名称：

  1-Alkyl-4-acylpiperazines as a New Class of Imidazole-Free Histamine H₃ Receptor Antagonists

  摘要：

  With the aim of identifying structurally novel, centrally acting histamine H-3 antagonists, arrays of monoacyldiamines were screened. This led to the discovery of a series of 1-alkyl-4-acylpiperazines which were potent antagonists at the human histamine H-3 receptor. The most potent amides had antagonist potencies in the subnanomolar range.

  DOI：

  10.1021/jm031028z
• 作为产物：
  描述：

  4-(1,1-dimethylpropyl)piperazine-1-carboxylic acid tert-butyl ester 生成 1-(2-甲基-2-丁烷基)哌嗪
  参考文献：
  名称：

  Substituted indoles as anti-AIDS pharmaceuticals

  摘要：

  式(I)的取代吲哚化合物是有用的抗艾滋病药物。

  公开号：

  US05599930A1

文献信息

• [EN] SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE<br/>[FR] MODULATEURS SÉLECTIFS DE LA PROTÉOLYSE DE LA LRRK2 MUTANTE ET MÉTHODES D'UTILISATION ASSOCIÉES
  申请人：ARVINAS OPERATIONS INC

  公开号：WO2021194878A1

  公开（公告）日：2021-09-30

  Bifunctional compounds, which find utility as modulators of non-receptor Leucine-rich repeat kinase 2 (LRRK2), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds LRRK2, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本文描述了作为非受体白氨酸富含重复激酶2（LRRK2）调节剂的双功能化合物。具体来说，本公开的双功能化合物在一端含有结合到 cereblon E3 泛素连接酶的基团，在另一端含有结合到 LRRK2 的基团，使得目标蛋白质靠近泛素连接酶以实现目标蛋白质的降解（和抑制）。本公开的双功能化合物表现出与目标蛋白质的降解/抑制相关的广泛药理活性。由于目标蛋白质异常调节导致的疾病或紊乱可通过本公开的化合物和组合物进行治疗或预防。
• Substituted indoles as anti-AIDS pharmaceuticals
  申请人：The Upjohn Company

  公开号：US05599930A1

  公开（公告）日：1997-02-04

  Substituted indoles of formula (I) ##STR1## are useful anti-AIDS pharmaceuticals.

  式(I)的取代吲哚化合物是有用的抗艾滋病药物。
• IMIDAZOPYRAZINES FOR USE AS KINASE INHIBITORS
  申请人：Pastor Fernández Joaquin

  公开号：US20120083492A1

  公开（公告）日：2012-04-05

  There is provided compounds of formula (I), wherein R 1 , R 2 , R 3 , R 4 and R 5 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PI3-K and/or mTOR) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.

  提供了式(I)的化合物，其中R1、R2、R3、R4和R5在描述中有给定的含义，以及它们的药用可接受的酯、酰胺、溶剂合物或盐，这些化合物在治疗需要或期望抑制蛋白质或脂质激酶（例如PI3-K和/或mTOR）的疾病方面非常有用，特别是在治疗癌症或增生性疾病方面。
• Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
  申请人：Lixte Biotechnology, Inc.

  公开号：US10668062B2

  公开（公告）日：2020-06-02

  A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure (I).

  一种通过使哺乳动物细胞与具有结构 (I) 的蛋白磷酸酶 2A (PP2A) 抑制剂接触来提高其胰岛素敏感性的方法。
• Anti-infective heterocyclic compounds and uses thereof
  申请人：Bioimics AB

  公开号：US11130741B2

  公开（公告）日：2021-09-28

  The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.

  本发明涉及可用作抗感染剂的式Ⅰ杂环化合物。本发明还涉及通过施用此类化合物治疗感染的方法，以及包含此类化合物的药物组合物。